Inovio Pharmaceuticals, Inc. (INO) Financials
Key financial figures for Inovio Pharmaceuticals, Inc. (Q2 2026).
Inovio Pharmaceuticals, Inc. reported revenue of $0.00 for Q2 FY2026. The company posted a net loss of $6.0 million, or -$0.07 per share. Free cash flow for the period was -$18.0 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Inovio Pharmaceuticals, Inc. are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$6M
- EPS
- $-0.07
- Total Assets
- $49M
- Operating Cash Flow
- -$18M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $0 | -$6M | -$0.07 | -$18M | |
| Q1 FY2026 | $0 | -$20M | -$0.28 | -$22M | |
| Q4 FY2025 | $0 | $4M | $0.05 | -$19M | |
| Q3 FY2025 | $0 | -$45M | -$0.87 | -$22M | |
| Q2 FY2025 | $0 | -$24M | -$0.61 | -$21M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $65K | -$85M | -$1.81 | -132871.32% | -$89M |
| FY2024 | $218K | -$107M | -$3.95 | -51616.91% | -$105M |
| FY2023 | $832K | -$135M | -$6.09 | -17300.28% | -$125M |
Frequently asked questions
What was Inovio Pharmaceuticals, Inc.'s revenue last quarter?
Inovio Pharmaceuticals, Inc. reported revenue of $0.00 for Q2 FY2026.
Is Inovio Pharmaceuticals, Inc. profitable?
Not in its most recent reported period. Inovio Pharmaceuticals, Inc. reported a net loss of $6.0 million for Q2 FY2026.
How much free cash flow did Inovio Pharmaceuticals, Inc. generate?
Inovio Pharmaceuticals, Inc. generated free cash flow of -$18.0 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Inovio Pharmaceuticals, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.